News

The new era of weight loss: Does GLP-1 live up to expectations?
GLP-1 drugs like Wegovy and Mounjaro have been hailed globally with promises of revolutionary treatments for obesity. But despite strong results...

Trump threatens 200 percent tariffs on pharmaceuticals
At a cabinet meeting on Tuesday, the US President announced...

New announcement from Japan strengthens Medivir's patent portfolio
The Japanese Patent Office has issued a Notice of...

BioStock Investor Pitch: AlzeCure Pharma
Swedish AlzeCure Pharma develops small molecule drug candidates for the treatment of...

In the shadow of the GLP-1 hype: new report criticizes pharmaceutical companies' patent strategies
A new report from the patent organization I-MAK sheds light...

Five Nordic biotech stock market winners in H1 2025
Vacation times are approaching and when 2025 is now...

Chugai and Gero in billion-dollar deal within AI
Chugai Pharmaceutical and Gero have entered into a joint...

AlzeCure's CEO: "Increased interest after EIC grant and FDA feedback"
Today marks the start of the subscription period for AlzeCure Pharma's rights issue,...

Karolinska Development's partner cancels development
Karolinska Development recently announced that its partner Organon has decided...

Cereno Scientific signs agreement with CRO for phase IIb study
Cereno Scientific has taken an important step towards...

Klaria Pharma's CEO comments on the ongoing capital raising
Klaria Pharma is about to take the next...

Sobi and Apellis update royalty agreement for Aspaveli
Sobi has entered into a new agreement with Apellis...
Notes
Alvotech acquires Ivers-Lee Group in Switzerland
OncoZenge enters into convertible loan with Linc
Merck close to buying Verona Pharma for USD 10 billion
Acarix takes first order in the MENA region
Modus Therapeutics completes recruitment in Phase IIa study
NEWSLETTER
NEWS
The new era of weight loss: Does GLP-1 live up to expectations?
Trump threatens 200 percent tariffs on pharmaceuticals
New announcement from Japan strengthens Medivir's patent portfolio
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles

The EU's new life science strategy – a step in the right direction or just fluff?

Early signs of spring in an otherwise frosty biotech landscape
